TBC1D4 Mutation Common in North American Inuit

Share this content:
<i>TBC1D4</i> Mutation Common in North American Inuit
TBC1D4 Mutation Common in North American Inuit

WEDNESDAY, Aug. 31, 2016 (HealthDay News) -- More than one-quarter of Canadian and Alaskan Inuit have the TBC1D4 mutation resulting in elevated postprandial glucose, and those with prediabetes and type 2 diabetes have increased risk of remaining undiagnosed, according to a study published online Aug. 25 in Diabetes Care.

Despoina Manousaki, M.D., from McGill University in Montreal, and colleagues examined the frequency and effect of the TBC1D4 mutation on glucose metabolism and type 2 diabetes diagnosis among Canadian and Alaskan Inuit. Exome sequencing was performed in 114 Inuit from Nunavik, Canada, and Sanger sequencing was performed in 1,027 Alaskan Inuit.

The researchers found that 27 percent of Canadian and Alaskan Inuit had the TBC1D4 mutation, which was strongly associated with higher glucose and insulin two hours after an oral glucose load in homozygote carriers. The odds of remaining undiagnosed were increased for TBC1D4 carriers with prediabetes and type 2 diabetes, compared with noncarriers, unless prostprandial glucose values were tested (odds ratio, 5.4). Thirty-two percent of carriers with prediabetes or type 2 diabetes would remain undiagnosed without an oral glucose tolerance test (OGTT).

"Disruption of TBC1D4 is common among North American Inuit, resulting in exclusively elevated postprandial glucose. This leads to underdiagnosis of type 2 diabetes, unless an OGTT is performed," the authors write. "Accounting for genetic factors in the care of Inuit with diabetes provides an opportunity to implement precision medicine in this population."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Opioid Rx, Dosing Often Excessive in Dialysis Patients

Opioid Rx, Dosing Often Excessive in Dialysis Patients

High-risk dialysis population also subject to the risks of long-term opioid use

Nonadherence to Statins  ACEIs/ARBs Risky Post MI

Nonadherence to Statins &#43; ACEIs/ARBs Risky Post MI

Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction

Pulse Ox  Auscultation Reliable for Congenital Heart Screening

Pulse Ox &#43; Auscultation Reliable for Congenital Heart ...

The method significantly improves detection rate of major CHD in newborns

is free, fast, and customized just for you!

Already a member?

Sign In Now »